Enhanced survival and function of neural stem cells-derived dopaminergic neurons under influence of olfactory ensheathing cells in parkinsonian rats

Journal of Neurochemistry

Volumn 109, Issue 2, 2009, Pages 436-451

  Shukla, Shubha ^a   Chaturvedi, Rajnish Kumar ^a   Seth, Kavita ^a   Roy, Neeta Singh ^b   Agrawal, Ashok Kumar ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

6 OHDA; Amphetamine; NSC; OEC; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; NEUROTROPHIN RECEPTOR P75; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; FEMALE; IN VITRO STUDY; MOTOR PERFORMANCE; NERVE FIBER GROWTH; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OLFACTORY ENSHEATHING CELL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REINNERVATION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DOPAMINE; FEMALE; NEUROGENESIS; NEURONS; OLFACTORY BULB; OLFACTORY MUCOSA; PARKINSON DISEASE; RATS; RATS, WISTAR; STEM CELLS;

ANIMALIA; PARKINSONIA; RATTUS;

EID: 62649090139     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.05983.x     Document Type: Article

References (69)

1. Abercrombie M. (1946) Estimation of nuclear population from microtome sections. Anat. Rec. 4, 239 247.
2. Agrawal A. K., Shukla S., Chaturvedi R. K., Seth K., Srivastava N., Ahmad A. Seth P. K. (2004a) Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells. Neurobiol Dis. 16, 516 526.
3. Agrawal A. K., Chaturvedi R. K., Shukla S., Seth K., Chauhan S., Ahmad A. Seth P. K. (2004b) Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease. J. Chem. Neuroanat. 28, 253 264.
4. Akerud P., Canals J. M., Snyder E. Y. Arenas E. (2001) Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J. Neurosci. 21, 8108 8118.
5. Alexi T., Borlongan C. V., Faull R. L., Williams C. E., Clark R. G., Gluckman P. D. Hughes P. E. (2000) Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog. Neurobiol. 60, 409 470.
6. Aszmann O. C., Korak K. J., Kropf N., Fine E., Aebischer P. Frey M. (2002) Simultaneous GDNF and BDNF application leads to increased motor-neuron survival and improved functional outcome in an experimental model for obstetric brachial plexus lesions. Plast. Reconstr. Surg. 110, 1066 1072.
7. Au E., Richter M. W., Vincent A. J., Tetzlaff W., Aebersold R., Sage E. H. Roskams A. J. (2007) SPARC from olfactory ensheathing cells stimulates Schwann cells to promote neurite outgrowth and enhances spinal cord repair. J. Neurosci. 27, 7208 7221.
8. Benedetti S., Pirola B., Pollo B. et al. (2000) Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. 6, 447 450.
9. Blochl A. Sirrenberg C. (1996) Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J. Biol. Chem. 271, 21100 21107.
10. Carvey P. M., Ling Z. D., Sortwell C. E., Pitzer M. R., McGuire S. O., Storch A. Collier T. J. (2001) A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp. Neurol. 171, 98 108.
11. Chaturvedi R. K., Agrawal A. K., Seth K., Shukla S., Chauhan S., Shukla Y., Sinha C. Seth P. K. (2003) Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies. Int. J. Dev. Neurosci. 21, 391 400.
12. Chaturvedi R. K., Shukla S., Seth K. Agrawal A. K. (2006a) Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease. Neurosci. Lett. 398, 44 49.
13. Chaturvedi R. K., Shukla S., Seth K., Chauhan S., Sinha C., Shukla Y. Agrawal A. K. (2006b) Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Neurobiol Dis. 22, 421 434.
14. Chaturvedi R. K., Shukla S., Seth K. Agrawal A. K. (2008) Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats. Exp. Neurol. 210, 608 623.
15. Chiang Y., Morales M., Zhou F. C., Borlongan C., Hoffer B. J. Wang Y. (2001) Fetal intra-nigral ventral mesencephalon and kidney tissue bridge transplantation restores the nigrostriatal dopamine pathway in hemi-parkinsonian rats. Brain Res. 889, 200 207.
16. Dewar D., Bentley D. Barnett S. C. (2007) Implantation of pure cultured olfactory ensheathing cells in an animal model of parkinsonism. Acta Neurochir (Wien). 149, 407 414.
17. Doucette R. (1990) Glial influences on axonal growth in the primary olfactory system. Glia. 3, 433 449.
18. Erickson J. T., Brosenitsch T. A. Katz D. M. (2001) Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo. J. Neurosci. 21, 581 589.
19. Fairless R. Barnett S. C. (2005) Olfactory ensheathing cells: their role in central nervous system repair. Int. J. Biochem. Cell Biol. 37, 693 699.
20. Gage F. H. (2000) Mammalian neural stem cells. Science 287, 1433 1438.
21. Granholm A.-C., Henry S., Hebert M. A., Eken S., Gerhardt G. A. Horne C. V. (1998) Kidney co-grafts enhance fiber outgrowth from ventral mesencephalic grafts to the 6-OHDA-lesioned striatum, and improve behavioral recovery. Cell Transplant. 7, 197 212.
22. Hagg T. (1998) Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp. Neurol. 149, 183 192.
23. Hagg T. Varon S. (1993) Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl. Acad. Sci. USA, 90, 6315 6319.
24. Johansson S., Lee I.-Hui., Olson L. Spenger C. (2005) Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions. Brain 128, 2961 2976.
25. Kearns C. M. Gash D. M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104 111.
26. Kondo J., Kitamura Y., Inden M. Taniguchi T. (2004) Hemiparkinsonian rat models: different sensitivity of dopaminergic neurotoxins. Int. Cong. Series. 260, 281 285.
27. Lee C. S., Cenci M. A., Schulzer M. Bjorklund A. (2000) Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain. 2000, 1365 1379.
28. Lindvall O., Kokaia Z. Martinez-Serrano A. (2004) Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10, S42 S50.
29. Mackay-Sim A. (2005) Olfactory ensheathing cells and spinal cord repair. Keio J. Med. 54, 8 14.
30. Melchior B., Nerriere-Daguin V., Laplaud D. A., Remy S., Wiertlewski S., Neveu I., Naveilhan P., Meakin S. O. Brachet P. (2003) Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection. Exp. Neurol. 183, 367 378.
31. Monje M. L., Toda H. Palmer T. D. (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760 1765.
32. Mufson E. J., Kroin J. S., Sendera T. J. Sobreviela T. (1999) Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57, 451 484.
33. Nash H. H., Borke R. C. Anders J. J. (2001) New method of purification for establishing primary cultures of ensheathing cells from the adult olfactory bulb. Glia. 34, 81 87.
34. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M. G. Bjorklund A. A. (1994) microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 63, 57 72.
35. Nishimura F., Yoshikawa M., Kanda S. et al. (2003) Potential use of embryonic stem cells for the treatment of mouse Parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells. 21, 171 180.
36. Olanow C. W., Goetz C. G., Kordower J. H. et al. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54, 403 414.
37. Ostenfeld T., Joly E., Tai Y. T., Peters A., Caldwell M., Jauniaux E. Svendsen C. N. (2002) Regional specification of rodent and human neurospheres. Brain Res. Dev. Brain Res. 134, 43 55.
38. Ourednik V., Ourednik J., Park K. I., Teng Y. D., Aboody K. A., Auguste K. I., Taylor R. M., Tate B. A. Snyder E. Y. (2000) Neural stem cells are uniquely suited for cell replacement and gene therapy in the CNS. Novartis Found. Symp. 231, 242 262.
39. Ourednik J., Ourednik V., Lynch W. P., Schachner M. Snyder E. Y. (2002) Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 20, 1103 1110.
40. Palfi S., Leventhal L., Chu Y., Ma S. Y., Emborg M., Bakay R., Deglon N., Hantraye P., Aebischer P. Kordower J. H. (2002) Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J. Neurosci. 22, 4942 4954.
41. Paxinos G. Watson C., eds (1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, California, USA.
42. Pearse D. D., Sanchez A. R., Pereira F. C. et al. (2007) Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. Glia. 55, 976 1000.
43. Pellitteri R., Spatuzza M. Russo A. (2007) Stanzani S.Olfactory ensheathing cells exert a trophic effect on the hypothalamic neurons in vitro. Neurosci. Lett. 417, 24 29.
44. Pluchino S., Zanotti L., Deleidi M. Martino G. (2005) Neural stem cells and their use as therapeutic tool in neurological disorders. Brain Res. Brain Res. Rev. 48, 211 219.
45. Ramon-Cueto A. Nieto-Sampedro M. (1992) Glial cells from adult rat olfactory bulb: immunocytochemical properties of pure cultures of ensheathing cells. Neuroscience 47, 213 220.
46. Ramon-Cueto A., Plant G. W., Avila J. Bunge M. B. (1998) Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J. Neurosci. 18, 3803 3815.
47. Richter M. W. Roskams A. J. (2008) Olfactory ensheathing cell transplantation following spinal cord injury: Hype or hope? Exp. Neurol. 209, 353 367.
48. Rosenblad C., Martinez-Serrano A. Bjorklund A. (1998) Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Neuroscience 82, 129 137.
49. Rothstein J. D. Snyder E. Y. (2004) Reality and immortality - neural stem cells for therapies. Nat Biotechnol. 22, 283 285.
50. Roy A., Agrawal A. K., Husain R., Dubey M. P. Seth P. K. (1999) Cholinergic and serotonergic alterations in the rat hippocampus following trimethyltin exposure and fetal neural transplantation. Neurosci. Lett. 259, 173 176.
51. Salinas M., Diaz R., Abraham N. G., Ruiz de Galarreta C. M. Cuadrado A. (2003) Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J. Biol. Chem. 278, 13898 13904.
52. Schumm M. A., Castellanos D. A., Frydel B. R. Sagen J. (2004) Improved neural progenitor cell survival when cografted with chromaffin cells in the rat striatum. Exp. Neurol. 185, 133 142.
53. Shimoke K. Chiba H. (2001) Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease. J. Neurosci. Res. 63, 402 409.
54. Shingo T., Date I., Yoshida H. Ohmoto T. (2002) Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J. Neurosci. Res. 69, 946 954.
55. Shukla S., Agrawal A. K., Chaturvedi R. K., Seth K., Srivastava N., Sinha C., Shukla Y., Khanna V. K. Seth P. K. (2004) Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine lesioned rats: implications for Parkinson's disease. J. Neurochem. 91, 274 284.
56. Slevin J. T., Gerhardt G. A., Smith C. D., Gash D. M., Kryscio R. Young B. (2005) Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J. Neurosurg. 102, 216 222.
57. Snyder B. J. Olanow C. W. (2005) Stem cell treatment for Parkinson's disease: an update for 2005. Curr. Opin. Neurol. 18, 376 385.
58. Song H. J., Stevens C. F. Gage F. H. (2002) Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons. Nat. Neurosci. 5, 438 445.
59. Storch A., Lester H. A., Boehm B. O. Schwarz J. (2003) Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cells. J. Chem. Neuroanat. 26, 133 142.
60. Stromberg I., Wetmore C. J., Ebendal T., Ernfors P., Persson H. Olson L. (1990) Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J. Neurosci. Res. 25, 405 411.
61. Studer L., Tabar V. McKay R. D. (1998) Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1, 290 295.
62. Takagi Y., Takahashi J., Saiki H. et al. (2005) Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest. 115, 102 109.
63. Temple S. (2001) Stem cell plasticity - building the brain of our dreams. Nat. Rev. Neurosci. 2, 513 520.
64. Toft A., Scott D. T., Barnett S. C. Riddell J. S. (2007) Electrophysiological evidence that olfactory cell transplants improve function after spinal cord injury. Brain 130, 970 984.
65. Wang X., Lu Y., Zhang H., Wang K., He Q., Wang Y., Liu X., Li L. Wang X. (2004) Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease. Int. J. Dev. Neurosci. 22, 175 183.
66. Weidner N., Blesch A., Grill R. J. Tuszynski M. H. (1999) Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J. Comp. Neurol. 413, 495 506.
67. Woodhall E., West A. K. Chuah M. I. (2001) Cultured olfactory ensheathing cells express nerve growth factor, brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. Brain Res. Mol. Brain Res. 88, 203 213.
68. Yasuhara T., Shingo T., Muraoka K. et al. (2005) Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease. J. Neurosurg. 102, 80 89.
69. Zawada W. M., Zastrow D. J., Clarkson E. D., Adams F. S., Bell K. P. Freed C. R. (1998) Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786, 96 103.